Optimizing MR-Guided Radiotherapy for Breast Cancer Patients

Current research in radiotherapy (RT) for breast cancer is evaluating neoadjuvant as opposed to adjuvant partial breast irradiation (PBI) with the aim of reducing the volume of breast tissue irradiated and therefore the risk of late treatment-related toxicity. The development of magnetic resonance (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Groot Koerkamp, Maureen L., Vasmel, Jeanine E., Russell, Nicola S., Shaitelman, Simona F., Anandadas, Carmel N., Currey, Adam, Vesprini, Danny, Keller, Brian M., De-Colle, Chiara, Han, Kathy, Braunstein, Lior Z., Mahmood, Faisal, Lorenzen, Ebbe L., Philippens, Marielle E. P., Verkooijen, Helena M., Lagendijk, Jan J. W., Houweling, Antonetta C., van den Bongard, H. J. G. Desiree, Kirby, Anna M.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7399349/
https://ncbi.nlm.nih.gov/pubmed/32850318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01107
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars